Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.
Status:
Unknown status
Trial end date:
2020-01-13
Target enrollment:
Participant gender:
Summary
This is a phase III study for evaluation of Nasotestt efficacy compared to Androgel in the
treatment of male participants with hypogonadism condition (reduced levels of testosterone)
that have clinical indication of hormonal replacement with testosterone.
Phase:
Phase 3
Details
Lead Sponsor:
FBM Industria Brasileira Ltda
Collaborators:
Azidus Brasil Pesquisa CientÃfica e Desenvolvimento Ltda Azidus Brasil Scientific Research and Development Ltda